According to Immunic's latest financial reports the company's current EPS (TTM) is -HK$26.60. In 2022 the company made an earnings per share (EPS) of -HK$29.24 an increase over its 2021 EPS that were of -HK$29.55.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$26.86 | -8.15% |
2022 | -HK$29.24 | -1.05% |
2021 | -HK$29.55 | 33.68% |
2020 | -HK$22.11 | -64.33% |
2019 | -HK$61.97 | -79.62% |
2018 | -HK$304.05 | -26.32% |
2017 | -HK$412.65 | 2.31% |
2016 | -HK$403.34 | -38.1% |
2015 | -HK$651.55 | -23.48% |
2014 | -HK$851.48 | -88.9% |
2013 | -HK$7,674 |